You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Atovaquone

Showing 1 - 25 of 59
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian High Grade Serous Adenocarcinoma, Platinum-Resistant Ovarian Carcinoma Trial in Atlanta (Atovaquone, Biopsy, Computed

Not yet recruiting
  • Ovarian High Grade Serous Adenocarcinoma
  • Platinum-Resistant Ovarian Carcinoma
  • Atovaquone
  • +3 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Aug 11, 2023

Acute Myeloid Leukemia Trial in Baltimore, Houston (Atovaquone, Cytarabine, Daunorubicin)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Atovaquone
  • +4 more
  • Baltimore, Maryland
  • +1 more
Oct 7, 2022

COVID-19 Trial in Dallas (Experimental Group, Placebo Group)

Completed
Has Results
  • COVID-19
  • Experimental Group
  • Placebo Group
  • Dallas, Texas
    University of Texas Medical Center
Dec 12, 2021

Covid19 Trial in Scottsdale (Atovaquone/Azithromycin)

Terminated
  • Covid19
  • Scottsdale, Arizona
    HonorHealth
Feb 16, 2022

Pneumonia, Pneumocystis Carinii, HIV Trial in Puerto Rico, United States (Atovaquone)

Completed
  • Pneumonia, Pneumocystis Carinii
  • HIV Infections
  • Atovaquone
  • San Francisco, California
  • +5 more
Oct 27, 2021

Locally Advanced NSCLC Trial in Edinburgh, London, Oxford (Atovaquone Oral Suspension, Standard of care chemo, Standard of care

Recruiting
  • Locally Advanced Non-Small Cell Lung Cancer
  • Atovaquone Oral Suspension
  • +2 more
  • Edinburgh, United Kingdom
  • +1 more
Dec 21, 2021

Toxoplasmosis, Cerebral, HIV Trial in United States (Sulfadiazine, Clarithromycin, Atovaquone)

Completed
  • Toxoplasmosis, Cerebral
  • HIV Infections
  • Los Angeles, California
  • +15 more
Oct 27, 2021

Malaria Infection Trial in Darmstadt (M5717 60 mg, Pyronaridine, Atovaquone-Proguanil)

Not yet recruiting
  • Malaria Infection
  • M5717 60 mg
  • +4 more
  • Darmstadt, Germany
    Research Site
Aug 2, 2023

Malaria Trial in Anlong Veng (atovaquone-proguanil, artesunate-atovaquone-proguanil)

Active, not recruiting
  • Malaria
  • Anlong Veng, Oddar Meancheay, Cambodia
    Anlong Veng Referral Hospital
Mar 1, 2021

Plasmodium Falciparum Malaria (Drug Resistant) Trial in Kratie, Stung Treng, Ânlóng Vêng (Artesunate and Pyronaridine,

Recruiting
  • Plasmodium Falciparum Malaria (Drug Resistant)
  • Artesunate and Pyronaridine
  • +2 more
  • Kratie, Cambodia
  • +2 more
Mar 1, 2021

HIV, Malaria Trial in Netherlands (Atovaquone / Proguanil)

Completed
  • HIV Infections
  • Malaria
  • Atovaquone / Proguanil
  • Tilburg, Brabant, Netherlands
  • +4 more
Nov 9, 2020

Gastroesophageal Reflux Disease Trial in Seoul (Atovaquone / Proguanil 250/100 mg, Tegoprazan 50 mg, Esomeprazole 40 mg)

Completed
  • Gastroesophageal Reflux Disease
  • Atovaquone / Proguanil 250/100 mg
  • +3 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital, Clinical Trial Center
Sep 23, 2021

Pneumonia, Pneumocystis Carinii, HIV Trial in Tanzania, United States (Atovaquone, Dapsone)

Completed
  • Pneumonia, Pneumocystis Carinii
  • HIV Infections
  • Birmingham, Alabama
  • +43 more
Oct 27, 2021

Rabies Trial in Syracuse (Chloroquine, Atovaquone and Proguanil, Doxycycline)

Completed
Has Results
  • Rabies
  • Syracuse, New York
    State University of New York, Upstate Medical University (SUNY-U
Apr 22, 2021

Plasmodium Falciparum, Malaria Trial in Tübingen (DSM265 400mg, Placebo to DSM265 400 mg, Plasmodium falciparum sporozoite

Completed
Has Results
  • Plasmodium Falciparum, Malaria
  • DSM265 400mg
  • +3 more
  • Tübingen, Germany
    Universitätsklinikum Tübingen, Institut für Tropenmedizin
Jan 7, 2021

Malaria Trial in Croydon (ATV-PG 1000-400 mg + AQ 612 mg)

Completed
  • Malaria
  • ATV-PG 1000-400 mg + AQ 612 mg
  • Croydon, London, United Kingdom
    Richmond Pharmacology Ltd.
Mar 17, 2020

NSCLC Trial in Oxford (Atovaquone)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Atovaquone
  • Oxford, Oxfordshire, United Kingdom
    Churchill Hospital
Sep 2, 2019

Plasmodium Falciparum Trial (atovaquone-proguanil)

Withdrawn
  • Plasmodium Falciparum
  • (no location specified)
May 6, 2020

Malaria Trial in Bethesda, Silver Spring (Chloroquine-Azithromycin (CQ/AZ), Chloroquine (CQ), atovaquone-proguanil (Malarone®))

Withdrawn
  • Malaria
  • Chloroquine-Azithromycin (CQ/AZ)
  • +2 more
  • Bethesda, Maryland
  • +1 more
Feb 25, 2020

Malaria,Falciparum, Gametocytes, Controlled Human Malaria Infection Trial in Nijmegen (Piperaquine (low dose), Piperaquine (high

Completed
Has Results
  • Malaria,Falciparum
  • +3 more
  • Piperaquine (low dose)
  • +5 more
  • Nijmegen, Gelderland, Netherlands
    Radboud university medical center
Jun 15, 2020

Malaria Trial (drug, biological, other)

Completed
  • Malaria
  • atovaquone/proguanil 250mg/100mg (A/P)
  • +2 more
  • (no location specified)
Jul 11, 2019

Malaria Trial in Kisumu (Artesunate, Malarone)

Completed
Has Results
  • Malaria
  • Kisumu, New Nyanza, Kenya
    New Nyanza Provincial Hospital
Sep 20, 2019

Pneumocystis Jirovecii Pneumonia in Non-HIV-infected

Active, not recruiting
  • Pneumocystis Jirovecii Infection
    • Vandoeuvre Les Nancy, Lorraine, France
      Université de Lorraine, CHRU Nancy and APEMAC
    Jul 12, 2022

    Exercise, Pharmacokinetics Trial run by the WRAIR (Malarone)

    Withdrawn
    • Exercise
    • Pharmacokinetics
    • Bethesda, Maryland
      Uniformed Services University
    Apr 27, 2021

    Covid19, Lung Inflammation, Hypoxemic Respiratory Failure Trial in Manhasset (Steroid Taper (Prednisone))

    Withdrawn
    • Covid19
    • +2 more
    • Steroid Taper (Prednisone)
    • Manhasset, New York
      Northwell Health
    Feb 1, 2022